SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of AmerisourceBergen

12

AmerisourceBergen

ABC

The Pennsylvania-based drug distributor saw revenues grow in 2017 thanks to increased business from some of its largest customers and strong sales of expensive cancer drugs. Amerisources’s animal health unit, MWI, also recorded strong sales growth thanks to its brisk pet medicine business. Profits took a hit due to accrued litigation costs from the previous year. Like other large drug distributors, Amerisource faces a number of lawsuits over its alleged role in the nation’s opioid epidemic.

Looking for leads, investment insights, or competitive intelligence?

CEO

Steven H. Collis

CEO Title

Chairman, President & Chief Executive Officer

Sector

Wholesalers

Industry

Wholesalers: Health Care

HQ Location

Chesterbrook, Pa.

Years on Fortune 500 List

24

Employees

19,500

Figures are for fiscal year ended Sept. 30, 2017.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$153,1444.3%
Profits ($M)$364.5-74.5%
Assets ($M)$35,317
Total Stockholder Equity ($M)$2,065
Market Value — as of March 29, 2018 ($M)$18,938
Profit Ratios
Profit as % of Revenues0.2%
Profits as % of Assets1.0%
Profits as % of Stockholder Equity17.7%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)1.64
EPS % Change (from 2016)-74.1%
EPS % Change (5 year annual rate)-10.1%
EPS % Change (10 year annual rate)2.8%
Total Return
Total Return to Investors (2017)19.4%
Total Return to Investors (5 year, annualized)18.0%
Total Return to Investors (10 year, annualized)16.6%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about AmerisourceBergen